Email this article to a friend
What do we know about communicating risk? A brief review and suggestion for contextualising serious, but rare, risk, and the example of cox-2 selective and non-selective NSAIDs
-
* Corresponding author: R Andrew Moore andrew.moore@pru.ox.ac.uk
Arthritis Research & Therapy 2008, 10:R20 doi:10.1186/ar2373